-
Validation of a novel quotient differentiating cognitive and motor-driven activity of daily living impairments in PD patients
-
Validation of Acoustic Analysis of Swallowing as a Method of Screening for Orofaringeal Dysfunction at Parkinson
-
Validation of the ‘ecological momentary assessment’ (EMA) method as a tool for daily life monitoring in patients with Parkinson’s disease
-
Validation of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson’s Disease
-
Validation of the diagnostic criteria for progressive supranuclear palsy in pathologically confirmed patients
-
Validation of the Hebrew version of the Unified Dyskinesia Rating Scale (UDysRS)
-
Validation of the Movement Disorder Society criteria for the diagnosis of 4R-tauopathies
-
Validation of the PREDIGT Score for the Incidence Rate of Parkinson disease
-
Validation of the Seoul-instrumental activity daily living in the detection of dementia in Parkinson disease
-
Variants in the beta-Glucocerebrosidase A (GBA) gene in German patients with Parkinson´s disease
-
Variations in Olfactory Neural Connections Associated with Cognition in Parkinson’s Disease
-
Vascular Parkinsonism and Parkinson’s Disease: clinical differences concerning balance impairment
-
Vascular risk factors and depression in multiple system atrophy
-
Vascular risk factors, WMLs and the risk of cognitive impairment in Parkinson disease: A longitudinal study from the Parkinson’s Disease Cognitive Impairment Study (PaCoS) cohort
-
Vascular white matter involvement in Idiopathic Normal Pressure Hydrocephalus: association with cognitive and motor impairment
-
Verbal Disfluencies in Parkinson´s Disease Spoken Discourse as a Function of Syntax Complexity
-
Vertebral pain and bone mineral density in women with Parkinson’s disease
-
VIM stimulation for refractory tremor -the Sheba experience
-
Virtual Reality EEG guided motor neurofeedback training has mid-term effects in Parkinson’s Disease Patients limits of stability
-
Visual assessment of dopamine transporter imaging in normal pressure hydrocephalus
-
Visual dysfunction and retinal thinning predict dementia risk in Parkinson’s disease
-
Visual evoked potentials alterations in DLB
-
Visual hallucinations in Lewy Body Disease are characterised by impaired sensory integration
-
Visual hallucinations in Parkinson´s disease and amyloid burden: 18F-Flutemetamol PET-MRI study
-
Visual sensory processing is altered in myoclonus dystonia
-
Visual subnetwork dysfunction in Parkinson’s patients with primary visual hallucinations
-
Visuoperceptual impairment: a key feature in the diagnosis of corticobasal degeneration
-
Visuospatial dysfunction correlates with severity of postural instability/gait disturbance symptoms in parkinson’s disease
-
Vocal cords electromyography abnormalities in multiple system atrophy phenotypes: relevance for the pathophysiology of stridor
-
Vortioxetine treatment of depression in Parkinson’s disease
2019 International Congress
September 22-26, 2019. Nice, France.